ClinConnect ClinConnect Logo
Search / Trial NCT06822205

Identification and Treatment of Renal Stenosis in Transplanted Kidneys

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 6, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to better understand and treat a condition called renal artery stenosis, which can happen after a kidney transplant. Renal artery stenosis occurs when the artery supplying blood to the transplanted kidney becomes narrowed, which can lead to kidney problems and even transplant failure if not treated. The study focuses on whether a specific treatment method called endovascular treatment—using techniques like angioplasty (a procedure to widen the artery) and stent placement (inserting a small tube to keep the artery open)—is effective for patients with this condition.

To participate in this trial, you need to be at least 18 years old, have received a kidney transplant, and have been diagnosed with renal artery stenosis. Participants will have the opportunity to receive the recommended treatment and help contribute to important research that could improve care for future kidney transplant patients. The trial is currently recruiting participants of all genders, and your involvement may help doctors better understand the best ways to treat this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age greater than or equal to 18 years
  • Indication of renal transplant and diagnosis of renal artery stenosis of the transplant
  • Obtaining informed consent
  • Exclusion Criteria:
  • -

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Mauro Gargiulo, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported